Choudhury, A. D., Gray, K. P., Supko, J. G., Harshman, L. C., Taplin, M., Pace, A. F., . . . Sweeney, C. (2018). A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer. Prostate.
Chicago Style CitationChoudhury, Atish D., et al. "A Dose Finding Clinical Trial of Cabozantinib (XL184) Administered in Combination With Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer." Prostate 2018.
MLA CitationChoudhury, Atish D., et al. "A Dose Finding Clinical Trial of Cabozantinib (XL184) Administered in Combination With Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer." Prostate 2018.
Warning: These citations may not always be 100% accurate.